Vigil Neuroscience Ownership | Who Owns Vigil Neuroscience?
Vigil Neuroscience Ownership Summary
Vigil Neuroscience is owned by 65.55% institutional investors, 21.27% insiders, and 13.18% retail investors. Atlas venture life science advisors is the largest institutional shareholder, holding 14.64% of VIGL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.74% of its assets in Vigil Neuroscience shares.
VIGL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Vigil Neuroscience | 65.55% | 21.27% | 13.18% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Atlas venture life science advisors | 5.84M | 14.64% | $23.35M |
| Northpond ventures | 4.21M | 10.57% | $16.86M |
| Artal group | 1.83M | 4.59% | $7.31M |
| Bvf inc/il | 1.81M | 4.55% | $7.25M |
| Sphera funds management | 1.69M | 4.24% | $6.77M |
| Point72 asset management | 1.49M | 3.73% | $5.94M |
| Citadel advisors | 1.44M | 3.62% | $5.77M |
| 683 capital management | 1.10M | 2.76% | $4.40M |
| Vanguard group | 814.73K | 2.04% | $3.26M |
| Stempoint capital lp | 744.41K | 1.87% | $2.98M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Northpond ventures | 4.21M | 30.50% | $16.86M |
| Atlas venture life science advisors | 5.84M | 2.46% | $23.35M |
| Pivotal bioventure partners investment advisor | 560.60K | 1.72% | $2.24M |
| Sphera funds management | 1.69M | 0.92% | $6.77M |
| Stempoint capital lp | 744.41K | 0.88% | $2.98M |
| 683 capital management | 1.10M | 0.33% | $4.40M |
| Bvf inc/il | 1.81M | 0.20% | $7.25M |
| Artal group | 1.83M | 0.19% | $7.31M |
| Deep track capital, lp | 597.22K | 0.07% | $2.39M |
| Rock springs capital management lp | 471.96K | 0.06% | $1.89M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 1.49M | 0.02% | 1.49M |
| Stempoint capital lp | 744.41K | 0.88% | 744.41K |
| Goldman sachs group | 401.14K | 0.00% | 382.90K |
| Millennium management | 334.81K | 0.00% | 301.68K |
| Woodline partners lp | 206.61K | 0.01% | 206.61K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | 597.22K | 0.07% | -997.72K |
| Deerfield management company, l.p. (series c) | - | - | -980.31K |
| Citadel advisors | 1.44M | 0.00% | -722.65K |
| Blackrock | 405.04K | - | -471.99K |
| State street | 40.74K | - | -245.32K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 1.49M | 0.02% | 1.49M | $5.94M |
| Stempoint capital lp | 744.41K | 0.88% | 744.41K | $2.98M |
| Woodline partners lp | 206.61K | 0.01% | 206.61K | $826.46K |
| Susquehanna group, llp | 48.05K | - | 48.05K | $192.20K |
| Qube research | 30.43K | 0.00% | 30.43K | $121.72K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -2.00 |
| New york state common retirement fund | -140.00 |
| Amalgamated bank | -542.00 |
| Ameritas investment partners | -1.33K |
| Legal & general group | -1.55K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 56 | 7.69% | 26,129,244 | -1.47% | 65 | 1.40% | 31 | 55.00% | 17 | 13.33% |
| Mar 31, 2024 | 52 | 13.04% | 26,518,676 | 6.23% | 68 | 1.66% | 20 | -9.09% | 15 | 25.00% |
| Dec 31, 2023 | 46 | 2.22% | 24,962,629 | -2.27% | 64 | 1.47% | 22 | 37.50% | 12 | - |
| Sep 30, 2023 | 45 | -4.26% | 25,543,602 | -0.81% | 66 | 1.48% | 16 | -40.74% | 12 | 50.00% |
| Jun 30, 2023 | 47 | 14.63% | 25,751,059 | 2.73% | 66 | 1.58% | 27 | 80.00% | 8 | -20.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 710.14K | 1.74% | - |
| abrdn Life Sciences Investors | 235.01K | 0.57% | - |
| BlackRock Health Sciences Term Trust | 215.43K | 0.54% | 8.07K |
| Vanguard Institutional Extnd Mkt Idx Tr | 170.24K | 0.43% | - |
| Fidelity Extended Market Index | 116.88K | 0.29% | 35.79K |
| Bridgeway Ultra-Small Company Market | 72.16K | 0.18% | 22.10K |
| NT R2000 Value Index Fund - NL | 42.43K | 0.11% | -6.83K |
| NT R2000 Index Fund - NL | 40.34K | 0.10% | -1.64K |
| iShares Micro-Cap ETF | 39.39K | 0.10% | - |
| Fidelity Total Market Index | 37.90K | 0.10% | 10.10K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 20, 2023 | Magovcevic-Liebisch Ivana | President and CEO | Buy | $15.00K |
| Nov 18, 2022 | Papapetropoulos Spyros | Chief Medical Officer | Sell | $4.20K |
| May 16, 2022 | Thorp Clay | Buy | $44.19K | |
| May 05, 2022 | Thackaberry Evan | SVP, Head of Early Development | Buy | $6.00K |
| May 03, 2022 | Verni Christopher | General Counsel | Buy | $15.07K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q4 | 1 | - |
| 2023 Q3 | - | - |
| 2023 Q2 | - | - |
VIGL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools